Woodline Partners LP Centessa Pharmaceuticals PLC Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Woodline Partners LP holds 516,379 shares of CNTA stock, worth $8.86 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

516,379

Previous 123,461 318.25%

Holding current value

$8.86 Million

Previous $1.11 Million 641.11%

% of portfolio

0.07%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.58 - $16.99 $3.37 Million - $6.68 Million	392,918 Added 318.25%	516,379 $8.26 Million
Q2 2024 Aug 14, 2024	BUY	$8.04 - $11.87 $992,626 - $1.47 Million	123,461 New	123,461 $1.11 Million
Q4 2023 Feb 14, 2024	SELL	$5.52 - $8.03 $382,800 - $556,864	-69,348 Reduced 32.99%	140,856 $1.12 Million
Q3 2023 Nov 14, 2023	SELL	$6.01 - $8.24 $2.87 Million - $3.94 Million	-477,559 Reduced 69.44%	210,204 $1.36 Million
Q2 2023 Aug 14, 2023	SELL	$3.68 - $6.9 $177,486 - $332,787	-48,230 Reduced 6.55%	687,763 $4.26 Million
Q1 2023 May 15, 2023	BUY	$3.03 - $4.0 $1.57 Million - $2.07 Million	516,573 Added 235.43%	735,993 $2.83 Million
Q4 2022 Feb 14, 2023	BUY	$3.05 - $4.19 $124,598 - $171,169	40,852 Added 22.88%	219,420 $680,000
Q3 2022 Nov 14, 2022	SELL	$3.8 - $5.91 $4.32 Million - $6.71 Million	-1,136,084 Reduced 86.42%	178,568 $718,000
Q2 2022 Aug 15, 2022	BUY	$3.18 - $9.85 $1.37 Million - $4.26 Million	432,019 Added 48.95%	1,314,652 $6.4 Million
Q1 2022 May 16, 2022	BUY	$7.45 - $11.59 $607,152 - $944,550	81,497 Added 10.17%	882,633 $7.92 Million
Q4 2021 Feb 14, 2022	SELL	$10.99 - $17.54 $897,630 - $1.43 Million	-81,677 Reduced 9.25%	801,136 $9.02 Million
Q3 2021 Nov 15, 2021	BUY	$16.7 - $23.11 $1.01 Million - $1.39 Million	60,295 Added 7.33%	882,813 $14.7 Million
Q2 2021 Aug 16, 2021	BUY	$21.71 - $25.66 $17.9 Million - $21.1 Million	822,518 New	822,518 $18.3 Million

Others Institutions Holding CNTA

# of Institutions

108

Shares Held

118M

Call Options Held

5.9K

Put Options Held

53K

View Full List

About Centessa Pharmaceuticals plc

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.62B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

More about CNTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Centessa Pharmaceuticals PLC Transaction History